Paper36971908
Oral delivery of RNAi for cancer therapy.
Afrin H and 5 others. Cancer Metastasis Rev, 2023. Cited by 29 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Oral delivery of RNAi for cancer therapy. Papers, record 36971908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36971908
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Review, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Humans | |
| RNA Interference | |
| RNA, Small Interfering | |
| Carcinogenesis | |
| Drug Delivery Systems |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R03 OD032624 | NIH HHS | United States | R03OD032624 | PubMed and NIH |
Source NIH RePORTER
References173
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9486653 | Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. | Nature | 1998 | https://conductscience.org/library/papers/9486653 | PubMed |
| 2 | 15644174 | RNA interference in Caenorhabditis elegans. | Methods Enzymol | 2005 | https://conductscience.org/library/papers/15644174 | PubMed |
| 3 | 28379201 | siRNA Delivery Strategies: A Comprehensive Review of Recent Developments. | Nanomaterials (Basel) | 2017 | https://conductscience.org/library/papers/28379201 | PubMed |
| 4 | 23727262 | A review of the current status of siRNA nanomedicines in the treatment of cancer. | Biomaterials | 2013 | https://conductscience.org/library/papers/23727262 | PubMed |
| 5 | 22737048 | Therapeutic siRNA: principles, challenges, and strategies. | Yale J Biol Med | 2012 | https://conductscience.org/library/papers/22737048 | PubMed |
| 6 | 11253050 | Post-transcriptional gene silencing by double-stranded RNA. | Nat Rev Genet | 2001 | https://conductscience.org/library/papers/11253050 | PubMed |
| 7 | 10778853 | RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. | Cell | 2000 | https://conductscience.org/library/papers/10778853 | PubMed |
| 8 | 20360048 | The siRNA sequence and guide strand overhangs are determinants of in vivo duration of silencing. | Nucleic Acids Res | 2010 | https://conductscience.org/library/papers/20360048 | PubMed |
| 9 | 10749213 | An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. | Nature | 2000 | https://conductscience.org/library/papers/10749213 | PubMed |
| 10 | 11498593 | Argonaute2, a link between genetic and biochemical analyses of RNAi. | Science | 2001 | https://conductscience.org/library/papers/11498593 | PubMed |
| 11 | 19422869 | siRNA delivery systems for cancer treatment. | Adv Drug Deliv Rev | 2009 | https://conductscience.org/library/papers/19422869 | PubMed |
| 12 | 12526743 | Short-interfering-RNA-mediated gene silencing in mammalian cells requires Dicer and eIF2C translation initiation factors. | Curr Biol | 2003 | https://conductscience.org/library/papers/12526743 | PubMed |
| 13 | 35908622 | Ionic liquid-mediated delivery of a BCL-2 inhibitor for topical treatment of skin melanoma. | J Control Release | 2022 | https://conductscience.org/library/papers/35908622 | PubMed |
| 14 | 17541417 | Interfering with disease: a progress report on siRNA-based therapeutics. | Nat Rev Drug Discov | 2007 | https://conductscience.org/library/papers/17541417 | PubMed |
| 15 | 22741011 | Silencing Notch-1 induces apoptosis and increases the chemosensitivity of prostate cancer cells to docetaxel through Bcl-2 and Bax. | Oncol Lett | 2012 | https://conductscience.org/library/papers/22741011 | PubMed |
| 16 | 31301483 | Overcoming multiple drug resistance in lung cancer using siRNA targeted therapy. | Gene | 2019 | https://conductscience.org/library/papers/31301483 | PubMed |
| 17 | 23289892 | Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. | ACS Nano | 2013 | https://conductscience.org/library/papers/23289892 | PubMed |
| 18 | 15520458 | Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. | Nucleic Acids Res | 2004 | https://conductscience.org/library/papers/15520458 | PubMed |
| 19 | 25103255 | Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. | Nat Rev Drug Discov | 2014 | https://conductscience.org/library/papers/25103255 | PubMed |
| 20 | 28779684 | Oral delivery of biologics using drug-device combinations. | Curr Opin Pharmacol | 2017 | https://conductscience.org/library/papers/28779684 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42110369 | A reduction-sensitive lipophilic dihydroartemisinin prodrug in a self-microemulsifying drug delivery system for treating breast cancer lung metastasis via intestinal lymphatic transport. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/42110369 | PubMed |
| 41907643 | Aptamers targeting immune checkpoints for tumor immunotherapy: a comprehensive review. | Front Oncol | 2026 | https://conductscience.org/library/papers/41907643 | PubMed |
| 41255464 | Nanomaterials for Theranostic Management of Oral Cancer: Advances in Imaging, Biosensing, Targeted Delivery, and Multimodal Synergistic Therapy. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41255464 | PubMed |
| 40720073 | Redox Signaling Disruption and Antioxidants in Toxicology: From Precision Therapy to Potential Hazards. | Cell Biochem Biophys | 2025 | https://conductscience.org/library/papers/40720073 | PubMed |
| 40508071 | Advances in Nanotechnology-Based Cisplatin Delivery for ORL Cancers: A Comprehensive Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40508071 | PubMed |
| 40490954 | The new era of siRNA therapy: Advances in cancer treatment. | Clin Transl Med | 2025 | https://conductscience.org/library/papers/40490954 | PubMed |
| 39871848 | Enhancing precision in cancer treatment: the role of gene therapy and immune modulation in oncology. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39871848 | PubMed |
| 39835546 | Exploring the Therapeutic Potential of TROP2 Gene Silencing in Hepatocellular Carcinoma. | Recent Pat Biotechnol | 2026 | https://conductscience.org/library/papers/39835546 | PubMed |
| 39219266 | The role of lncRNA binding to RNA‑binding proteins to regulate mRNA stability in cancer progression and drug resistance mechanisms (Review). | Oncol Rep | 2024 | https://conductscience.org/library/papers/39219266 | PubMed |
| 38689935 | Recent insights into breast milk microRNA: their role as functional regulators. | Front Nutr | 2024 | https://conductscience.org/library/papers/38689935 | PubMed |
| 38683256 | The application of plant-exosome-like nanovesicles as improved drug delivery systems for cancer vaccines. | Discov Oncol | 2024 | https://conductscience.org/library/papers/38683256 | PubMed |
| 38556942 | What is the role of microbial biotechnology and genetic engineering in medicine? | Microbiologyopen | 2024 | https://conductscience.org/library/papers/38556942 | PubMed |
| 38140636 | Gene-Editing and RNA Interference in Treating Hepatitis B: A Review. | Viruses | 2023 | https://conductscience.org/library/papers/38140636 | PubMed |
| 38003296 | Human Breast Milk miRNAs: Their Diversity and Potential for Preventive Strategies in Nutritional Therapy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003296 | PubMed |
| 37350332 | β-Glucan-Mediated Oral Codelivery of 5FU and Bcl2 siRNA Attenuates Stomach Cancer. | ACS Appl Mater Interfaces | 2023 | https://conductscience.org/library/papers/37350332 | PubMed |
Genes28
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36971908
GET https://conductscience.org/api/papers/v1/36971908/references?page=2